June 2009 – Vol 11 – No. 2
State of the art
Epidemiology of Alzheimer’s disease: occurrence, determinants, and strategies toward intervention
Chengxuan Qiu, MD, PhD; Miia Kivipelto, MD, PhD; Eva von Strauss, PhD
Novel strategies for the prevention of dementia from Alzheimer’s disease
Diana W. Shineman, PhD
Early detection of Alzheimer’s disease: new diagnostic criteria
Bruno Dubois, MD, PhD
Biological markers for early detection and pharmacological treatment of Alzheimer’s disease
Harald Hampel, MD, MA, MSc; Karl Broich, MD; Yvonne Hoessler, MA; Johannes Pantel, MD, PhD
Mechanism-based treatments for Alzheimer’s disease
Peter Davies, PhD
Is there a neuropathology difference between mild cognitive impairment and dementia?
Vahram Haroutunian, PhD
Structural neuroimaging in Alzheimer’s disease: do white matter hyperintensities matter?
Adam M. Brickman, PhD; Jordan Muraskin, BS; Molly E. Zimmerman, PhD
Imaging in Alzheimer’s disease
Philip Scheltens , MD, PhD
The effects of cardiovascular risk factors on cognitive compromise
Michal Schnaider Beeri, PhD; Ramit Ravona-Springer, MD; Jeremy M. Silverman, PhD; Vahram Haroutunian, PhD
Is dementia preventable?
Amos D. Korczyn, MD; MSc
Family caregivers of people with dementia
Henry Brodaty, MD; DSc; FRACP; FRANZCP; Marika Donkin, BA-Psychology (Rons); Grad’DipProf Ethics